Nanobiotix designs and manufactures nanoparticles that safely enhance the efficacy of radiation therapy in the treatment of cancer. It develops new tools for cancer that utilise a physical mode of action at the cellular level of the cancer cell. The Company’s NanoXray technology comprises three products. Local treatment (surgery and radiotherapy) provides potential cure and gives the systemic treatment a better chance to life expectancy. NanoXray products are developed for the efficacy of radiotherapy in the tumour cell. Nanobiotix is a spin-off of the State University of New York (SUNY) at Buffalo.